Head-to-head · Value Score
Sesame Care vs HealthRX
Two GLP-1 deals, scored on the same six factors. Sesame Care lands a Value Score of 87, HealthRX a 86. Here's who gives you the honest lower price — and where each one bites back.
Sesame Care
#5 · Grade A- · Great Deal
Est. first month
$149/mo
Save ~89% vs brand-nameHealthRX
#7 · Grade A- · Great Deal
Est. first month
$190/mo month-to-month ($99 first month, renews at $165)
Save ~86% vs brand-nameThe verdict
Sesame Care takes it on Value Score, 87 to 86 — an est. $149/mo first month, though we flag its pricing to watch. HealthRX isn't out of it: Needle-averse shoppers who want a verified, physician-supervised program with a real oral GLP-1 tablet option and don't need a published state list.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Sesame Care | HealthRX |
|---|---|---|
| Value Score | 87 (A-) | 86 (A-) |
| Est. first month | $149/mo | $190/mo month-to-month ($99 first month, renews at $165) |
| Save vs brand-name | ~89% | ~86% |
| Semaglutide | Care $59/mo only on the 12-month prepay, otherwise $99 billed every 28 days (13 charges a year) — plus the drug: brand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg | $190/mo month-to-month ($99 first month, renews at $165) · $133/mo on a 3-month plan · $99/mo on a 12-month prepay ($1,188) |
| Tirzepatide | Care $59/mo on the 12-month prepay, otherwise $99 per 28 days — plus the drug: brand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg) | $239/mo month-to-month ($149 first month, renews at $214) · $209/mo on a 3-month plan · $179/mo on a 12-month prepay ($2,148) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | Nationwide marketplace | Not publicly listed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Sesame Care
An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
Why it's a deal
- Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
- Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
- You choose the provider and see the price up front — genuine marketplace transparency
- Oral routes available (Wegovy pill, Rybelsus)
The fine print
- A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
- Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
- Brand-name cash prices can run high without insurance
HealthRX
A LegitScript-certified, physician-supervised program that's one of the few offering a genuine oral GLP-1 tablet alongside injectable — with transparent flat monthly pricing and no insurance required.
Why it's a deal
- LegitScript-certified (#50087439) — a genuine third-party trust signal
- Physician-supervised telehealth with licensed-provider intake
- Both molecules plus a rare oral GLP-1 tablet for the needle-averse
- Transparent flat monthly pricing with no insurance required
The fine print
- Compounded medication is not FDA-approved
- The advertised entry rates are plan prices - $133 and $209 need three months, $99 and $179 need twelve - so month to month costs $190 and $239
- Brand-name tiers are an expensive pass-through (Ozempic ~$1,299/mo)
- States served are not publicly listed — confirm coverage before you sign up
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Sesame Care is ranked on the Sesame Care alternatives ranking, and the same list for the other side is on alternatives to HealthRX.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.